Posts Tagged ‘aromatase inhibitors’

December 9th, 2010

Meta-Analysis Finds Aromatase Inhibitors Increase Risk for Heart Disease

A new meta-analysis has found that postmenopausal women taking aromatase inhibitors (AIs) instead of tamoxifen to treat breast cancer appear to be at increased risk for cardiovascular complications. The results were presented at the San Antonio Breast Cancer Symposium. Previous studies suggested that women taking AIs were more likely to develop cardiovascular disease, while women taking […]